Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HOXC6 | hg38_v1_chr12_+_53994874_53994944 | -0.12 | 5.0e-01 | Click! |
HOXA7 | hg38_v1_chr7_-_27156646_27156693 | 0.12 | 5.2e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_89027700 Show fit | 4.34 |
ENST00000483158.1
|
immunoglobulin kappa variable 3-11 |
|
chr9_+_122371014 Show fit | 4.20 |
ENST00000362012.7
|
prostaglandin-endoperoxide synthase 1 |
|
chr9_+_122371036 Show fit | 3.83 |
ENST00000619306.5
ENST00000426608.6 ENST00000223423.8 |
prostaglandin-endoperoxide synthase 1 |
|
chr2_+_90172802 Show fit | 3.46 |
ENST00000390277.3
|
immunoglobulin kappa variable 3D-11 |
|
chr9_+_122370523 Show fit | 3.29 |
ENST00000643810.1
ENST00000540753.6 |
prostaglandin-endoperoxide synthase 1 |
|
chr2_-_89143133 Show fit | 3.27 |
ENST00000492167.1
|
immunoglobulin kappa variable 3-20 |
|
chr19_+_49513353 Show fit | 2.89 |
ENST00000596975.5
|
Fc fragment of IgG receptor and transporter |
|
chr6_+_113857333 Show fit | 2.74 |
ENST00000612661.2
|
myristoylated alanine rich protein kinase C substrate |
|
chr2_+_90038848 Show fit | 2.54 |
ENST00000390270.2
|
immunoglobulin kappa variable 3D-20 |
|
chr2_+_87338511 Show fit | 2.47 |
ENST00000421835.2
|
immunoglobulin kappa variable 3/OR2-268 (non-functional) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 12.7 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.5 | 11.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.2 | 7.8 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.0 | 6.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 3.3 | GO:0003094 | glomerular filtration(GO:0003094) |
1.0 | 2.9 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.1 | 2.7 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 2.5 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.5 | 2.4 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.1 | 1.9 | GO:0043249 | erythrocyte maturation(GO:0043249) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 11.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 4.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.7 | 3.3 | GO:0071753 | IgM immunoglobulin complex(GO:0071753) IgM immunoglobulin complex, circulating(GO:0071754) pentameric IgM immunoglobulin complex(GO:0071756) |
0.9 | 2.7 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 2.7 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 2.7 | GO:0035579 | specific granule membrane(GO:0035579) |
0.0 | 2.2 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 2.0 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 2.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 1.9 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 18.6 | GO:0003823 | antigen binding(GO:0003823) |
2.3 | 11.3 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.0 | 3.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.7 | 2.9 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.0 | 2.7 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 1.9 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 1.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 1.6 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.0 | 1.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 1.3 | GO:0015266 | protein channel activity(GO:0015266) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 1.8 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 1.7 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 1.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.7 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 10.6 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 3.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 2.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.6 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 1.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 1.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |